Inactive Instrument
CannPal Animal Therapeutics Limited Stock
Stocks
CP1
AU000000CP17
Biotechnology & Medical Research
| 1 day | +6.25% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2016-06-02 | |
Baden Bowen
DFI | Director of Finance/CFO | - | 2016-09-30 |
Rayson Tan
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2016-06-02 | |
Geoff Starr
CHM | Chairman | - | 2017-07-06 |
Kathryn Adams
BRD | Director/Board Member | - | 2017-03-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.25% | +13.33% | - | - | 12.26M | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +0.98% | +2.26% | +12.91% | +82.98% | 55.53B | |
| +1.75% | +2.76% | +12.38% | +103.69% | 53.03B | |
| -1.43% | -1.17% | +26.27% | +55.26% | 45.99B | |
| -0.48% | -2.80% | +18.01% | +99.11% | 42.45B | |
| +0.82% | +1.37% | +227.94% | +936.89% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +44.58% | +102.84% | +88.74% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | +0.29% | +3.82% | +52.36% | +163.03% | 43.62B | |
| Weighted average by Cap. | -0.11% | +3.13% | +49.45% | +160.62% |
Employees
-
